MedPath
NMPA Approval

Enoxaparin Sodium Injection

国药准字HJ20240045

June 25, 2024

Drug Information

依诺肝素钠注射液

注射剂

0.4ml: 4000AXaIU

化学药品

June 25, 2024

June 24, 2029

Company Information

Applicant Company

Julian Camarillo, 35 28037 Madrid Spain

Manufacturing Company

rovi pharma industrial services, s.a.

C/Julian Camarillo, 35 28037 Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依诺肝素钠注射液 - NMPA 批准文号 | MedPath